The present invention implements a strategy that combines an enzyme inhibition assay with a chemical dereplication process to identify active plant extracts and the particular compounds—diarylalkanes and/or diarylalkanols within those extracts that specifically inhibit binuclear enzyme function. Included in the present invention are compositions of matter comprised of one or more of diarylalkanes and/or diarylalkanols, which inhibit the activity of binuclear enzymes, particularly tyrosinase and which prevent melanin overproduction. The present invention also provides a method for inhibiting the activity of a binuclear enzyme, particularly tyrosinase and a method for preventing and treating diseases and conditions related to binuclear enzyme function. The present invention further includes a method for preventing and treating melanin overproduction and diseases and conditions of the skin related thereto. The method for preventing and treating diseases and conditions related to binuclear enzyme function and melanin overproduction is comprised of administering to a host in need thereof an effective amount of a composition comprising one or more diarylalkanes and/or diarylalkanols synthesized and/or isolated from one or more plants together with a pharmaceutically acceptable carrier.
本发明实施了一种策略,将酶抑制测定与
化学去重复过程相结合,以识别活性
植物提取物和特定化合物——二芳基
烷烃和/或二芳基醇,这些化合物特异性地抑制双核酶功能。本发明包括由一种或多种二芳基
烷烃和/或二芳基醇组成的物质组合物,其抑制双核酶的活性,特别是
酪氨酸酶,并防止
黑色素过度产生。本发明还提供了一种抑制双核酶活性的方法,特别是
酪氨酸酶,以及一种预防和治疗与双核酶功能相关的疾病和病况的方法。本发明还包括一种预防和治疗
黑色素过度产生以及与之相关的皮肤疾病和病况的方法。预防和治疗与双核酶功能和
黑色素过度产生相关的疾病和病况的方法包括向需要的宿主施用由一种或多种植物合成和/或分离的一种或多种二芳基
烷烃和/或二芳基醇组成的组合物的有效量,以及药用载体。